Indefinite Delivery Contract SPE2DX15D1002

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award IDC, valued at up to $999,999,999.00, serves as the primary vehicle for AmerisourceBergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract encompasses an extensive array of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The contract is not designated with any set-aside requirements, indicating open competition. In addition to the DLA contract, AmerisourceBergen holds a smaller IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.

The awarded task orders under this IDC demonstrate the diverse range of pharmaceutical and medical supplies being procured, such as various prescription drugs, vaccines, medical devices, and over-the-counter medications. The task orders cover a wide spectrum of therapeutic areas, including cardiovascular health, diabetes management, mental health treatments, pain management, infectious disease prevention, and general medical care. The contract deliveries are centralized at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, enabling the efficient fulfillment of orders for the DLA and other federal agencies.